P

ProQR Therapeutics NV
D

PRQR

1.34500
USD
-0.11
(-7.24%)
مفتوح الان
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
29,585
الربح لكل سهم
-0
العائد الربحي
-
P/E
-3
حجم السوق
189,805,098
أصول ذات صلة

العنوان: ProQR Therapeutics NV

القطاع: الرعاية الصحية
الصناعة: Biotechnology
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.